TrialHeadache2020

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies.

Todd A Smitherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.